PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 185 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $242,000 | -90.7% | 7,931 | -76.8% | 0.00% | -100.0% |
Q1 2022 | $2,604,000 | +1182.8% | 34,201 | +909.2% | 0.01% | – |
Q4 2021 | $203,000 | +1.5% | 3,389 | -4.4% | 0.00% | -100.0% |
Q3 2021 | $200,000 | -1.5% | 3,546 | +4.8% | 0.00% | 0.0% |
Q2 2021 | $203,000 | -14.7% | 3,383 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $238,000 | +19.0% | 3,374 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $200,000 | -23.1% | 3,374 | -22.9% | 0.00% | 0.0% |
Q3 2020 | $260,000 | +26.8% | 4,374 | +12.2% | 0.00% | 0.0% |
Q2 2020 | $205,000 | -13.5% | 3,900 | -29.5% | 0.00% | -50.0% |
Q4 2018 | $237,000 | -13.5% | 5,535 | -1.2% | 0.00% | 0.0% |
Q3 2018 | $274,000 | -0.4% | 5,603 | -6.6% | 0.00% | 0.0% |
Q4 2017 | $275,000 | +21.7% | 6,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $226,000 | +3.2% | 6,000 | +44.7% | 0.00% | +100.0% |
Q1 2016 | $219,000 | -32.6% | 4,147 | -1.8% | 0.00% | -75.0% |
Q4 2015 | $325,000 | – | 4,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |